Preprint / Version 1

Protein Engineering and Computational Analysis of Enzymes to Predict Cancer Mutations

##article.authors##

  • Nolan Sarmiento Student

DOI:

https://doi.org/10.58445/rars.1025

Keywords:

Protein engineering, computational analysis, cancer mutations, enzymes

Abstract

Cancer is a dangerous disease that can manifest in multiple forms and areas within the body. Due to its multifaceted nature and tenacity, cancer prevention and treatment methods remain challenging. However, developing methods are ongoing that may help with fighting cancer by engaging in preventing growth at early stages. Protein engineering and enzyme design is a promising field that allows proteins to be strategically edited and designed to target cancers more efficiently. Computational methods allow us to obtain a better understanding of how these proteins can be engineered to fight a disease like cancer. Computational software offers data on protein alignments over multiple species, theoretical protein structures, and predicting co-evolving enzyme pairs, as well as making inferences on how mutations affect residues. Here, I aimed to examine computational protein engineering by exploring predictive software that is publicly accessible, to gain insight into their abilities and draw conclusions on the relation between cancer malignancies and the computational results. Overall, computational analysis and understanding enzyme design can have exciting implications for the world of medicine and allow for robust means of treating diseases like cancer.

References

Ciccarone, F., Di Leo, L., Lazzarino, G., Maulucci, G., Di Giacinto, F., Tavazzi, B., & Ciriolo, M. R. (2020). Aconitase 2 inhibits the proliferation of MCF-7 cells promoting mitochondrial oxidative metabolism and ROS/FoxO1-mediated autophagic response. British journal of cancer, 122(2), 182–193. https://doi.org/10.1038/s41416-019-0641-0

Gulati, P., & Singh, C. V. (2024). The Crucial Role of Molecular Biology in Cancer Therapy: A Comprehensive Review. Cureus, 16(1), e52246. https://doi.org/10.7759/cureus.52246

Qin, L.-H., Hu, W., & Long, Y.-Q. (2018). Bioorthogonal Chemistry: Optimization and application updates during 2013–2017. Tetrahedron Letters, 59(23), 2214–2228. https://doi.org/10.1016/j.tetlet.2018.04.058

Murugan, A. K., & Alzahrani, A. S. (2022). Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas. British journal of biomedical science, 79, 10208. https://doi.org/10.3389/bjbs.2021.10208

Sequeiros-Borja, C. E., Surpeta, B., & Brezovsky, J. (2021). Recent advances in user-friendly computational tools to engineer protein function. Briefings in bioinformatics, 22(3), bbaa150. https://doi.org/10.1093/bib/bbaa150

Suplatov, D., Sharapova, Y., Timonina, D., Kopylov, K., & Švedas, V. (2018). The visualCMAT: A web-server to select and interpret correlated mutations/co-evolving residues in protein families. Journal of bioinformatics and computational biology, 16(2), 1840005. https://doi.org/10.1142/S021972001840005X

Yakhini, Z., & Jurisica, I. (2011). Cancer computational biology. BMC bioinformatics, 12, 120. https://doi.org/10.1186/1471-2105-12-120

Zheng, L., Zhan, Y., Lu, J., Hu, J., & Kong, D. (2021). A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer. Annals of translational medicine, 9(8), 680. https://doi.org/10.21037/atm-21-1010

Downloads

Posted

2024-03-16